Our studies and those of other groups indicated moderate or low activity of known CDK8 inhibitors on CRC cell lines in vitro, therefore we have focused on leukemia cells which were found to be sensitive to CA [4]. The gene discussed is CDK8; the disease is colorectal carcinoma.